Importance of Probiotics in Healthy and Pathological State of Human Organism

• Autorzy: Katarzyna Wojciechowska

Warianty tytułu

Rola probiotyków w stanie zdrowia i choroby organizmu ludzkiego

• Języki publikacji: EN

Abstrakty

EN

The intestinal microbiota involves a wide diversity of bacterial species and many of them cannot yet be cultured. They play different roles that are important for the host and have been associated with improving homeostasis. The introduction of beneficial bacterial species to the gastro intestinal tract of the host may be a very attractive option to re-establish the microbial equilibrium and prevent diseases. The species which are most commonly used in probiotic preparations are: Lactobacillus, Bifidobacterium, Escherichia, Enterococcus, Bacillus, Streptococcus and some Saccharomyces fungal strains. The manipulation of the host microflora may represent a new possibility in the prevention or management of many disorders. The aim of this paper is to review the new facts about the use of probiotics in healthy and pathological state of human organism. (original abstract)

W skład mikroflory układu pokarmowego wchodzi wiele gatunków bakterii. Pełnią one różne ważne funkcje, które umożliwiają zachowanie homeostazy organizmowi ludzkiemu. Wprowadzenie dodatkowych, korzystnych dla gospodarza szczepów bakteryjnych może uzu­pełnić ewentualne niedobory mikroflory oraz zapobiegać chorobom przewodu pokarmowego. Lactobacillus, Bifidobacterium, Escherichia, Enterococcus, Bacillus, Streptococcus oraz nie­które szczepy Saccharomyces stanowią grupę najczęściej używanych probiotyków. Możliwo­ści manipulowania i oddziaływania na mikroflorę gospodarza stanowią ważny środek prewencyjny niektórych schorzeń. Celem pracy jest przedstawienie nowych faktów dotyczących zastosowania probiotyków w stanie zdrowia i choroby organizmu ludzkiego. (abstrakt oryginalny)

Słowa kluczowe

EN

Food; Functional food; Health

PL

Żywność; Żywność funkcjonalna; Zdrowie

• Czasopismo: Towaroznawcze Problemy Jakości
• Rocznik: 2013
• Numer: nr 2
• Strony: 54--61

Twórcy

autor

Katarzyna Wojciechowska

• Medical University of Lublin, Poland

Bibliografia

• [1] Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
• [2] Neish A.S. (2009) Microbes in gastrointestinal health and disease. Gastroenterology, 136, 65-80.
• [3] Zoetendal E.G., Vaughan E.E., de Vos W.M. (2006) A microbial world within us. Mol. Microbiol., 6, 1639-1650.
• [4] Kleessen В., Bezirtzoglou E., Matto J. (2000) Culture-based knowledge on biodiversity, development and stability of human gastrointestinal microflora. Micr. Ecol. Health Dis., 2, 53-63.
• [5] Gupta V., Garg R. (2009) Probiotics. Indian J. Med. Microbiol., 27, 202-209.
• [6] Piano M.D., Carmagnola S., Ballare M., Balzarini M., Montino F., Pagliarulo M., Anderloni A., Orsello M., Tari R., Sforza F., Mogna L., Mogna G. (2012) Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form. J. Clin. Gastroenterol., 46, 85-91.
• [7] Kelly D., Conway S., Aminov R. (2005) Commensal gut bacteria: mechanisms of immune modulation. Trends in Immunology, 26, 326-333.
• [8] Bezirtzoglou E., Stavropoulou E. (2011) Immunology and probiotic impact of the newborn and young children intestinal microflora. Anaerobe, 17, 369-374.
• [9] Bron P.A., van Baarlen P., Kleerebezem M. (2012) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat. Rev. Microbiol, 10, 66-78.
• [10] Hell M" Bernhofer C., Stalzer P., Kern J.M., Claassen E. (2013) Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Beneficial Microbes, 4, 39-51.
• [11] Clemente J.C., Ursell L.K., Parfrey L.W. (2012) The impact of gut microbiota on human health: An integrated view. Cell, 16, 1258-1270.
• [12] Canani R.B., Di Costanzo M. (2013) Microbiota as potential therapeutic target for the treatment of cow's milk allergy. Nutrients, 5, 651-662.
• [13] Majamaa H., Isolauri E. (1970) A novel approach in the management of food allergy. J. Allergy Clin. Immun., 99, 179-185.
• [14] Tlaskalová-Hogenová H., Stepánková R., Hudcovic T., Tucková L., Cukrowska В., Lodinová-Zádmková R., Kozáková H., Rossmann P., Bártová J., Sokol D., Funda D. Borovská D., Reháková Z., Śinkora J., Hofman J., Drastich P., Kokesová A. (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters, 93, 97-108.
• [15] Cani P.D., Delzenne N.M. (2007) Gut microflora as a target for energy and metabolic homeostasis. Curr. Opinion Clin. Nutr. Metab. Care, 10, 729-734.
• [16] Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444, 1027-1031.
• [17] Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. (2006) Microbial ecology: human gut microbes associated with obesity. Nature, 444, 1022-1023.
• [18] Diamant M., Blaak E.E., de Vos W.M. (2011) Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?. Obesity reviews, 12, 272-281.
• [19] Sanz Y., Santacruz A., Gauffin P. (2010) Probiotics in the defence and metabolic balance of the organizm.Gut microbiota in obesity and metabolic disorders. Proceedings of the Nutrition Society, 69, 434^4-41.
• [20] Bukowska H., Pieczul-Mróz J., Jastrzębska M., Chełkowski К., Naruszewicz M. (1998) Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis, 137,437-438.
• [21] Kiessling G., Schneider J., Jahreis G. (2001) Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur. J. Clin. Nutr., 56, 843- -849.
• [22] Geier M.S., Butler R.N., Howarth G.S. (2006) Probiotics, Prebiotics and Synbiotics. A Role in Chemoprevention for Colorectal Cancer?. Cancer Biology & Therapy, 10, 1265-1269.
• [23] Spanhaak S., Havenaar R" Schaafsma G. (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr, 52, 899-907.
• [24] Zsivkovits M., Fekadu К., Sontag G., Nabinger U., Huber W.W., Kundi M., Chakraborty A., Foissy H.. Knasmuller S. (2003) Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains. Carcinogenesis, 24, 1913-1918.
• [25] Bauer M.P., Van Dissel J.T. (2009) Alternative strategies for Clostridium difficile infection. International Journal of Antimicrobial Agents, 33, 51-56.
• [26] Cunningham-Rundles S., Ahrné S., Johann-Liang R" Abuav R., Dunn-Navarra A., Grassey С., Bengmark S., Cervia J.S. (2011) Effect of probiotic bacteria on microbial host defense, growth, and immune function in Human Immunodeficiency Virus Type-1 Infection. Nutrients, 3, 1042-1070.
• [27] Borriello S.P. (1990) The influence of the normal flora on Clostridium difficile colonisation of the gut. Ann Med, 22, 61-67.
• [28] Sartor R.B. (2004) Therapeutic manipulation of the enteric microflora in inflamematory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology, 126, 1620-1633.
• [29] Gori A., Tincati C., Rizzardini G., Torti C., Quirino T., Haarman M., Ben Amor K., van Schaik J., Vriesema A., Knol J. (2008) Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J. Clin. Microbiol., 46, 757-758.
• [30] Bengmark S., Jeppsson B. (1995) Gastrointestinal surface protection and mucosa reconditioning. J Parenter Enteral Nutr, 19,410-415.
• [31] Spear G.T., Sikaroodi M., Zariffard M.R.. Landay A.L., French A.L., Gillevet P.M. (2008) Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV- uninfected women with or without bacterial vaginosis. J. Infect. Dis., 198, 1131-1140.
• [32] Silvi S., Verdenelli M.C., Orpianesi C" Cresci A. (2003) EU project Crownalife: functional foods, gut microflora and healthy ageing Isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J. Food Eng., 56, 195-200.